Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000653310 | SCV000775189 | benign | Epilepsy, familial focal, with variable foci 3 | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001637113 | SCV001851594 | benign | not provided | 2019-01-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001637113 | SCV002497829 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | NPRL3: BS1 |
ARUP Laboratories, |
RCV000653310 | SCV004564651 | likely benign | Epilepsy, familial focal, with variable foci 3 | 2023-10-17 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003965411 | SCV004783121 | benign | NPRL3-related condition | 2019-12-23 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV001637113 | SCV001928410 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001637113 | SCV001969272 | likely benign | not provided | no assertion criteria provided | clinical testing |